Kinaset Therapeutics Debuts Positive Outcomes Data from Phase 1b Study of KN-002 at the 2024 American Thoracic Society (ATS) International Conference [Yahoo! Finance]
Philip Morris International Inc (PM)
Last philip morris international inc earnings: 4/21 06:59 am
Check Earnings Report
US:NYSE Investor Relations:
pmi.com/investor-relations/overview
Company Research
Source: Yahoo! Finance
– Outcomes support evaluation of KN-002 in patients with eosinophilic and non-eosinophilic moderate to severe asthma and chronic obstructive pulmonary disease (COPD) – BOSTON, May 21, 2024 BUSINESS WIRE Kinaset Therapeutics , a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced positive outcomes from Part 2 of a multi-part Phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of its orally inhaled pan-JAK inhibitor KN-002. The data will be presented at the 2024 American Thoracic Society (ATS) International Conference. This randomized, double-blind, placebo-controlled study reported no safety or tolerability concerns after the 10-day administration of daily doses =16 mg in subjects with mild asthma who were naïve to inhaled corticosteroid therapy. Additionally, the once- and twice-daily administration of KN-002 resulted in rapid and clinically relevant reductions in fra
Show less
Read more
Impact Snapshot
Event Time:
PM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PM alerts
High impacting Philip Morris International Inc news events
Weekly update
A roundup of the hottest topics
PM
News
- Philip Morris International to Fund Law Clinics in Expansion of the Organization's U.S. Veterans Program [Yahoo! Finance]Yahoo! Finance
- Philip Morris International to Fund Law Clinics in Expansion of the Organization’s U.S. Veterans ProgramBusiness Wire
- Is Philip Morris International Inc. (NYSE:PM) the Top Dividend Stock to Buy in 2024 According to Billionaire Paul Tudor Jones? [Yahoo! Finance]Yahoo! Finance
- Best Stock to Buy Right Now: Philip Morris International vs. British American Tobacco [Yahoo! Finance]Yahoo! Finance
- Zyn shortages continue. But the popular nicotine pouches will be back on more shelves later this year, an executive says. [Business Insider]Business Insider
PM
Earnings
- 4/23/24 - Beat
PM
Analyst Actions
- 4/24/24 - Stifel
PM
Sec Filings
- 6/7/24 - Form 8-K
- 6/6/24 - Form CERT
- 6/6/24 - Form 8-A12B
- PM's page on the SEC website